2021-01-20 02:05:43 GMT2021-01-20 10:05:43(Beijing Time) Xinhua English
BRASILIA, Jan. 19 (Xinhua) Brasilia on Tuesday launched vaccination against COVID-19 with the CoronaVac vaccine developed by Chinese laboratory Sinovac in collaboration with the Sao Paulo-based Butantan Institute.
The first capital resident to receive the vaccine was 31-year-old nurse Lidia Rodrigues Dantas at the Da Asa Norte Regional Hospital, followed by five other frontline healthcare workers.
Federal District Governor Ibaneis Rocha, city Health Secretary Osnei Okumoto and other local officials were on hand for the event, which officially kicked off the city s immunization campaign. We hope that the entire population will be vaccinated as soon as possible to put an end to the pandemic, said Ibaneis, adding that all on-duty hospital staff were to be vaccinated Tuesday.
2021-01-20 16:56 By: Xinhua
BRASILIA, Jan. 19 (Xinhua) Brasilia on Tuesday launched vaccination against COVID-19 with the CoronaVac vaccine developed by Chinese laboratory Sinovac in collaboration with the Sao Paulo-based Butantan Institute.
The first capital resident to receive the vaccine was 31-year-old nurse Lidia Rodrigues Dantas at the Da Asa Norte Regional Hospital, followed by five other frontline healthcare workers.
Federal District Governor Ibaneis Rocha, city Health Secretary Osnei Okumoto and other local officials were on hand for the event, which officially kicked off the city s immunization campaign. We hope that the entire population will be vaccinated as soon as possible to put an end to the pandemic, said Ibaneis, adding that all on-duty hospital staff were to be vaccinated Tuesday.
Brazil official: China vaccine capable of preventing disease, death chinadaily.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinadaily.com.cn Daily Mail and Mail on Sunday newspapers.
A Chinese vaccine has been found to be significantly less effective than previous data had suggested, even as the Brazilian research institute that conducted the phase 3 clinical trials urges the public not to focus on the new efficacy rate. The SAo Paulo-based Butantan Institute - which is running final-stage clinical trials for CoronaVac, manufactured by Beijing-based Sinovac - submitted new data to Brazil's health regulator on Tuesday,.
Sinovac Biotech Ltd may further optimize its vaccines in late-stage clinical trials and release efficacy data along with results obtained from Indonesia and Turkey in 15 days to meet the increasing international demand for its vaccines, Chinese experts said on Thursday, after Brazil postponed the release of detailed data on the effectiveness of the vaccines co-developed by the Sao Paulo-based Butantan Institute.